These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21868324)

  • 21. Early changes in serum IL-6 and VEGF levels predict clinical outcome following first-line therapy in aggressive non-Hodgkin's lymphoma.
    Pedersen LM; Klausen TW; Davidsen UH; Johnsen HE
    Ann Hematol; 2005 Aug; 84(8):510-6. PubMed ID: 15834569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum and urine levels of interleukin-8 in patients with non-Hodgkin's lymphoma.
    Lee HL; Eom HS; Yun T; Kim HJ; Park WS; Nam BH; Moon-Woo S; Lee DH; Kong SY
    Cytokine; 2008 Jul; 43(1):71-5. PubMed ID: 18502145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
    Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
    Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The International Prognostic Index can be used as a guide to treatment decisions regarding patients with human immunodeficiency virus-related systemic non-Hodgkin lymphoma.
    Rossi G; Donisi A; Casari S; Re A; Cadeo G; Carosi G
    Cancer; 1999 Dec; 86(11):2391-7. PubMed ID: 10590382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of TNF alpha and its p55 soluble receptor in malignant lymphomas.
    Warzocha K; Salles G; Bienvenu J; Barbier Y; Bastion Y; Doche C; Rieux C; Coiffier B
    Leukemia; 1997 Apr; 11 Suppl 3():441-3. PubMed ID: 9209418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
    Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
    Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical observation of the changes of serum helper T-lymphocytes (TH) cytokines in patients with HIV-infection and opportunistic infection].
    Rao HP; Feng L; Li D; Bader A; Wu NP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jan; 41(1):42-5. PubMed ID: 17484210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma.
    Milanovic N; Matkovic S; Ristic D; Jelic S; Petrovic M
    J BUON; 2012; 17(3):497-501. PubMed ID: 23033288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma glutathione S-Transferase P1-1 as a prognostic factor in patients with advanced non-Hodgkin's lymphoma (stages III and IV).
    Katahira T; Takayama T; Miyanishi K; Hayashi T; Ikeda T; Takahashi Y; Takimoto R; Matsunaga T; Kato J; Niitsu Y
    Clin Cancer Res; 2004 Dec; 10(23):7934-40. PubMed ID: 15585627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prognostic significance of serum levels of soluble intercellular adhesion molecules-1 in patients with primary extranodal non-Hodgkin lymphomas.
    Lei KI; Johnson PJ
    Cancer; 2000 Sep; 89(6):1387-95. PubMed ID: 11002235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of interleukin-10 level and human leukocyte antigen-DR expression as prognostic predictors in critically ill patients undergoing continuous renal replacement therapy].
    Fu LJ; Yu C; Gong DH; Ji DX; Liu ZH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Mar; 24(3):140-4. PubMed ID: 22401157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical features, treatment and prognosis of 136 patients with primary non-Hodgkin's lymphoma of the nasopharynx].
    Yuan ZY; Li YX; Zhao LJ; Gao YH; Liu XF; Gu DZ; Qian TN; Yu ZH
    Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):425-9. PubMed ID: 15355649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
    Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
    Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenesis-related growth factors and cytokines in the serum of patients with B non-Hodgkin lymphoma; relation to clinical features and response to treatment.
    Passam FH; Sfiridaki A; Pappa C; Kyriakou D; Petreli E; Roussou PA; Alexandrakis MG
    Int J Lab Hematol; 2008 Feb; 30(1):17-25. PubMed ID: 18190463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
    Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
    Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of tissue factor and vascular endothelial growth factor expressions on CD14+ monocytes in patients with non Hodgkin lymphoma].
    Wang HX; Li XM; Han XH; Jiang YJ; Zhu GH; Zhuang WC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Aug; 33(4):427-31. PubMed ID: 21906453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of interleukin-4 and interleukin-18 levels in aggressive non-Hodgkin's lymphoma patients.
    Soydinc HO; Guney N; Basaran M; Duranyildiz D; Yasasever V
    Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor.
    Blay JY; Burdin N; Rousset F; Lenoir G; Biron P; Philip T; Banchereau J; Favrot MC
    Blood; 1993 Oct; 82(7):2169-74. PubMed ID: 8400266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between coagulation function and international prognostic index in lymphoma patients].
    Jiang YJ; Li XM; Han XH; Zhu GH; Zhuang WC; Gu J; Kang LL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1489-93. PubMed ID: 21176357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.